![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Rani Fariz A. Byrne Patrick
Publisher: Adis International
ISSN: 0114-5916
Source: Drug Safety, Vol.34, Iss.9, 2011-09, pp. : 773-781
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
By Ackers Ruth Besag Frank M.C. Hughes Elaine
Drug Safety, Vol. 34, Iss. 5, 2011-05 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Drug Safety, Vol. 32, Iss. 11, 2009-11 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
By DiSantostefano Rachael L. Davis Kourtney J.
Drug Safety, Vol. 34, Iss. 6, 2011-06 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
By Park Inwhee
American Journal of Cardiovascular Drugs, Vol. 12, Iss. 4, 2012-08 ,pp. :